检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王玉强[1] 王飞[1] 曹青[1] 苏靖[2] 盛净[3] 陈书艳[1]
机构地区:[1]上海交通大学医学院附属新华医院老年科,上海200092 [2]上海交通大学药学院,上海200240 [3]上海交通大学医学院附属第九人民医院老年科,上海200011
出 处:《现代生物医学进展》2014年第7期1267-1270,共4页Progress in Modern Biomedicine
基 金:国家自然科学基金项目(81001416;81270205)
摘 要:目的:研究交联小分子量聚乙烯亚胺衍生物PEI-Et对大鼠肝细胞(BRL-3A)的细胞毒性、转染效率和携带高血压相关基因血管紧张素原(AGT)短发卡RNA(shRNA)沉默AGT表达的能力。方法:MTT法检测PEI-Et/shRNA复合物对BRL-3A细胞的毒性,流式细胞术检测PEI-Et/shRNA复合物对BRL-3A细胞的转染效率,RT-PCR和Western blot检测PEI-Et/shRNA对AGT的基因沉默效果。结果:在相同质量比(w/w)时PEI-Et/shRNA的细胞毒性小于PEI 25kDa/shRNA(P<0.01),PEI-Et/shRNA在w/w为30时达到最高转染效率,高于PEI 25 kDa(P<0.01),PEI-Et/shRNA能高效沉默BRL-3A细胞中AGT基因的表达。结论:PEI-Et在BRL-3A细胞中是一种低细胞毒性、高转染效率的非病毒基因载体(与商业化的PEI 25kDa比较),能携带AGT shRNA高效沉默BRL-3A细胞中AGT基因的表达,通过用PEI-Et/AGT shRNA来抑制AGT的表达将为高血压的基因治疗提供一种新的思路。Objective: To synthesize cross-linked small-molecular-weight polyethylenimine derivative PEI-Et and investigate its cytotoxicity, transfection efficiency and ability to delivery hypertension related gene angiotensinogen (AGT) short hairpin RNA (shRNA) to silence AGT expression. Methods: MTT assay was used to measure the cytotoxicity of PEI-Et/shRNA complexes. Flow cytometry was performed to investigate transfection efficiency of PEI-Et/shRNA in BRL-3A cells. RT-PCR and Western blot were used to detect the AGT gene silencing effect of PEI-Et/shRNA. Results: PEI-Et/shRNA showed lower cytotoxicity than PEI 25kDa/shRNA at the same weight ratio (w/w). Transfection results indicated that PEI-Et/shRNA displayed the highest transfection efficiency at w/w 30, which was higher than PEI 25kDa/shRNA (P〈0.01). PEI-Et/shRNA could efficiently inhibit the expression of AGT in BRL-3A cells. Conclusion: PEI-Et was a non-viral vector with much lower cytotoxicity and enhanced transfection efficiency than PEI 25kDa in BRL-3A cells, and it could delivery AGT shRNA to efficiently silence AGT expression in BRL-3A cells. Therefore, PEI-Et/AGTshRNA would be a promising tool for delivering AGT shRNA to BRL-3A cells for hypertension therapy.
关 键 词:AGT RNA干扰 BRL-3A 转染效率 细胞毒性
分 类 号:Q813[生物学—生物工程] R915[医药卫生—微生物与生化药学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.104